Loading organizations...
Key people at Amil.
Founded in 1978 by Edson de Godoy Bueno, São Paulo, Brazil-based Amil provides comprehensive health and dental insurance plans alongside operating a large proprietary network of hospitals, medical centers, and clinics. The company generates revenue through premium-based subscriptions from corporate employers, families, and individual clients seeking managed healthcare and direct medical services across the country. Operating at a massive national scale, the organization currently serves approximately 5.4 million health and dental beneficiaries, manages over 30 hospitals, and maintains a direct workforce of more than 20,000 employees. In December 2023, former parent company UnitedHealth Group agreed to sell the healthcare business to Brazilian entrepreneur José Seripieri Filho for approximately $2.2 billion, or 11 billion Brazilian Reais. This major acquisition subsequently received official regulatory approval in early 2024 from Brazil's antitrust regulator CADE and the National Supplementary Health Agency.
Amil Participações S.A. (AMIL3) is a leading Brazilian healthcare company that provides comprehensive health plans, including medical, hospital, outpatient, and dental services, while owning and operating hospitals, maternity wards, emergency rooms, and diagnostic centers.[1][2] It serves individual, family, and corporate clients with services like hospital care, medical procedures, urgent care, clinical exams, and health research, positioning itself as a premium innovator in Brazil's health sector with products such as Amil One (exclusive premium plans), Amil Fácil (cost-effective regional plans), and Amil Dental (online-accessible dental coverage).[1][2][4][6]
Founded in 1978, Amil grew to become Latin America's largest healthcare company by combining operational expertise with a vast network of hospitals, clinics, and labs across Brazil, headquartered in Rio de Janeiro (with some references to São Paulo operations).[1][2][3][4] Formerly a subsidiary of UnitedHealth Group (acquired in 2012), it emphasizes innovation, transparency, and efficiency, driving sustainable relationships in the health ecosystem.[1][2][3][6]
Amil was founded in 1978 by Edson Bueno and Dulce Bueno in Rio de Janeiro, Brazil, starting as a health insurance startup amid growing demand for private healthcare.[1][2][3] The Bueno family built it into Brazil's top healthcare provider through decades of innovation and expansion; by 2007, Amil went public on the Brazilian stock exchange (B3: AMIL3), solidifying its market leadership.[3]
In 2012, UnitedHealth Group acquired a controlling stake in a landmark deal—the largest U.S. investment in a Brazilian company at the time—with Edson Bueno joining UHG's board.[1][2][3] This acquisition marked Amil's evolution from a family-led operator to a global-backed powerhouse, while the Bueno family later channeled their expertise into DNA Capital in 2013, investing in healthcare ventures worldwide.[3]
Amil rides Brazil's booming private healthcare trend, where public system gaps (SUS overload) drive demand for efficient, tech-enabled private plans amid aging populations and rising chronic diseases.[1][6] Its timing capitalized on 1970s liberalization of health insurance and 2010s digital health surge, with UnitedHealth's 2012 buyout accelerating tech integration like claims processing and telehealth precursors.[2][3][4]
Market forces favor Amil: regulatory support for innovation (ANS licensing), post-pandemic digital adoption, and economic shifts boosting corporate wellness spending.[4][6] It influences Brazil's ecosystem by setting premium standards, enabling family-backed spinouts like DNA Capital (now global VC/PE in health tech), and pioneering scalable models that blend traditional care with emerging tech like diagnostics and AI-driven personalization.[3][6]
Amil's trajectory points to deeper tech infusion—expanding telehealth, AI diagnostics, and data-driven plans amid Brazil's digital health boom and global partnerships post-UHG era.[4] Trends like value-based care, regulatory digitization, and LatAm expansion will shape it, potentially amplifying influence via DNA Capital's venture arm targeting health startups.[3][6]
As Latin America's healthcare pioneer, Amil remains poised to redefine accessible, innovative care, evolving from Bueno family vision to a tech-powered leader sustaining its ecosystem dominance.[1][3]
Key people at Amil.
